Term
|
Definition
| Antibiotic- tolerance develops rapidly |
|
|
Term
|
Definition
| Antibiotic- 1st line therapy |
|
|
Term
|
Definition
| Antibiotic- tolerance develops rapidly |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Proton Pump Inhibitor- creates basic enviornment. drug interactions |
|
|
Term
|
Definition
| Proton Pump Inhibitor- creates basic enviornment |
|
|
Term
|
Definition
| Proton Pump Inhibitor- creates basic enviornment |
|
|
Term
|
Definition
| Proton Pump Inhibitor- creates basic enviornment |
|
|
Term
|
Definition
| H2 receptor antagonists, ↓ gastric acid secretion. OTC. Short t1/2. drug interactions! rarely elevate prolactin levels |
|
|
Term
|
Definition
| H2 receptor antagonists, ↓ gastric acid secretion. OTC. longer acting, more potent |
|
|
Term
|
Definition
| H2 receptor antagonists, ↓ gastric acid secretion. OTC. most potent |
|
|
Term
|
Definition
| H2 receptor antagonists, ↓ gastric acid secretion |
|
|
Term
| Rare condition in which a gastrin- producing tumor causes hypersecretion of HCL |
|
Definition
| Zollinger- Ellison Syndrome |
|
|
Term
|
Definition
| inhibit secretion of HCl and stimulate secretion of mucus & bicarbonate. less effective than H2 antagonists for acute treatment of PUD |
|
|
Term
|
Definition
| prostaglandin- approved for prevention of gastric ulcers induced by NSAIDs. CI in in pregnancy- abortifacient |
|
|
Term
|
Definition
| ↑ GI motility and secretory activity, use as adjuncts in management of PUD & Zollinger- Ellison syndrome |
|
|
Term
|
Definition
|
|
Term
|
Definition
| antimuscarinic agent, specific M1 receptor antagonists, antisecretory agent |
|
|
Term
|
Definition
| H+/K+- ATPase proton pump inhibitors- supress secretion of the H+ ions into the gastric lumen. Direct antimicrobial action against H. Pylori |
|
|
Term
|
Definition
| weak bases that react with gastric acid to form water & a salt- diminish gastric acidity, also diminishes pepsin activity, reduce H. Pylori |
|
|
Term
| Aluminum & Magnesium (Maalox) |
|
Definition
| antacid- promote healing of duodenal ulcers |
|
|
Term
|
Definition
| antacid- stimulate gastrin release |
|
|
Term
| Sodium Bicarbonate (Alkaseltzer) |
|
Definition
| antacid- systemic absorption of can produce transient metablic alkalosis- no long term use |
|
|
Term
| mucosal protective agents |
|
Definition
| cytoprotective actions that enhance mucosal protection mechanisms heal existing duodenal (not gastric) ulcers |
|
|
Term
|
Definition
| complex of aluminum hydroxide & sulfated sucrose- forms gels, produces protective barrier. does not work with antacids, H2 antagonists, or PPI |
|
|
Term
| Bismuth Subsalicylate (Pepto Bismal) |
|
Definition
| effectively heals peptic ulcers, w. antimicrobial actions. inhibit activity of pepsin, ↑ mucus secretion. also used in antidiarrheals |
|
|
Term
|
Definition
| substitutied Benxamide- antiemetic, antidopaminergic |
|
|
Term
| Prochlorperazine (Compazine) |
|
Definition
| Phenothiazine- antiemetic- blocks dopamine receptors |
|
|
Term
|
Definition
| Butyropenones- antiemetic. block dopamine receptor, moderately effective |
|
|
Term
|
Definition
| Butyropenones- antiemetic. block dopamine receptor, moderately effective |
|
|
Term
|
Definition
| antiemetic-5HT3 serotonin receptor blockers in brain and periphery |
|
|
Term
|
Definition
| antiemetic-5HT3 serotonin receptor blockers in brain and periphery |
|
|
Term
|
Definition
| benzodiazepine- antiemetic, low potency, more sedative, anziolytic anmesic. useful in anticipatory vomiting |
|
|
Term
|
Definition
| benzodiazepine- antiemetic, low potency, more sedative, anziolytic anmesic. useful in anticipatory vomiting |
|
|
Term
|
Definition
| corticosteroid also used as antiemetic. for mild to moderate |
|
|
Term
| Methylprednisolone (Medrol) |
|
Definition
| corticosteroid also used as antiemetic. for mild to moderate |
|
|
Term
|
Definition
| Substance P/ Neurokinin 1 receptor blocker- only used against moderate to high emetics. j |
|
|
Term
|
Definition
| cannabinoid- antiemetic, marijuana derivatives effective against moderate emetogenic chemotherapy |
|
|
